| ORIGINAL ARTICLE
|Year : 2011 | Volume
| Issue : 2 | Page : 143--145
Low molecular weight heparin: A practical approach in deep venous thrombosis in palliative care
Samrat Dutta, Subrata Chattopadhayay, C Dasgupta, Shyamal Sarkar
Department of Radiotherapy, Medical College and Hospital, Kolkata, India
Introduction: Deep vein thrombosis (DVT) is one of the many cause of pain in advance cases of carcinoma cervix. The most widely used agent for combating DVT is unfractionated heparin.
Aims: Aims of this study is to see the efficacy of the use of low molecular weight (LMW) haparin and its practical utility in palliative care settings.
Materials and Methods: Twelve cases of established DVT received enoxaparin at 40 mg/m with warfarin.
Results: There was 70% resolution of limb swelling in seven cases. Out of remaining four cases took two months to resolve and one case did not resolve completely.
Conclusions: LMV heparin is effective in palliative care setting and also has added advantage of subcutaneous route of administration.
Department of Radiotherapy, Medical College and Hospital, Kolkata
Source of Support: None, Conflict of Interest: None
[FULL TEXT] [PDF]*